Merck has 41 disclosed EU lobbying meetings from 2024-09-30 to 2026-06-02: 20 with the European Commission and 21 with Members of the European Parliament. Source: EU Transparency Register no. 49654992078-52, Commission disclosures and MEP declarations. Methodology
Merck
EU lobbying footprint — who they meet, and on what.
- Register no.
- 49654992078-52 ↗
- Disclosed meetings
- 41 (20 Commission · 21 MEP)
- Period
- 2024-09-30 → 2026-06-02
Declared fields of interest: Budget · Business and industry · Climate action · Competition · Consumers · Customs · Digital economy and society · Economy, finance and the euro · Environment · External relations · Foreign affairs and security policy · Institutional affairs
Lobbying profile
as declared 2025-12-16- Category
- Companies & groups
- Legal status
- KGaA
- Declared lobbying cost
- €1,750,000
- Lobbying FTEs
- 4.45
- Members
- 3
At a glance
- Technology5
- Health4
- Industry2
- Transport1
- Trade1
- Vesna Loncaric1
- Stefan Fuehring1
- Jan Hendrik Dopheide1
- Tomas Baert1
- Arthur Corbin1
Disclosed meetings
Newest first. EC = European Commission, EP = Member of the European Parliament.
- 2026-06-02ECVesna Loncaric · Cabinet of Commissioner Dubravka ŠuicaHealthcare, including access to fertility treatment.source ↗
- Biotech Actsource ↗
- Meeting on EU health policysource ↗
- 2026-05-21ECStefan Fuehring · Head of UnitSingle Market, "One Europe, One Market Roadmap"source ↗
- European Biotech Actsource ↗
- 2026-03-10ECJan Hendrik Dopheide · Cabinet of Commissioner Maroš ŠefčovičIntroductory meeting / competitiveness and trade policysource ↗
- 2025-12-04ECTomas Baert · Cabinet of President Ursula von der LeyenPresentation of the three work streams of the EU-Japan Business Round Tablesource ↗
- Health Policysource ↗
- 2025-11-06ECArthur Corbin · Cabinet of Executive Vice-President Stéphane SéjournéExchange of views on industrial policiessource ↗
- Equine Health Technologiessource ↗
- 2025-10-20ECEva Schultz · Cabinet of Executive Vice-President Roxana MînzatuMeeting on the fertility matters in relation to EU Gender Equality and Demography Strategiessource ↗
- 2025-10-15ECAlexandr Hobza · Cabinet of Executive Vice-President Stéphane SéjournéExchange of views on regulatory environment for Life Sciences Manufacturing sectorsource ↗
- 2025-10-01ECSonia Vila Nunez · Cabinet of Executive Vice-President Roxana MînzatuTo formally present and discuss the Movement +Fertility, and the Portuguese Manifesto for reproductive equality and a sustainable future.source ↗
- Pharmaceuticalssource ↗
- 2025-09-09ECBoriša Falatar · Cabinet of Commissioner Hadja Lahbibgender equality and strengthening health preparednesssource ↗
- 2025-07-10ECGabriela Tschirkova · Cabinet of Commissioner Valdis Dombrovskiscompetitivenesssource ↗
- 2025-07-10ECOlivér Várhelyi · Cabinet of Commissioner Olivér VárhelyiExchange of views on the EU pharma and health policy matterssource ↗
- 2025-07-03ECJana Dabbelt · Cabinet of Commissioner Olivér Várhelyi• Intro to company • pharma legislation and CMA • UWWTP and health-specific policies (mental health, fertility, cancer and cardiovascular health)source ↗
- Critical medicines actsource ↗
- 2025-07-01ECGiulia Del Brenna · Head of UnitThe specifics of life science-related upcoming initiatives, including the new Bioeconomy Strategy, the Biotech Act, and Life Science Strategy.source ↗
- 2025-06-27ECMichael McGrath · Cabinet of Commissioner Michael McGrathExchange of views on issues relating to competitiveness and corporate sustainabilitysource ↗
- FutURe Projectsource ↗
- Health policysource ↗
- Innovation und nachhaltiges Wachstum: Ein Realitätscheck für Europas strategische Ambitionensource ↗
- New EU Pharmaceutical Legislationsource ↗
- 2025-05-21ECOlivier Girard · Head of UnitDiscussion on availability and access to medical countermeasures manufactured by Mercksource ↗
- 2025-04-29ECAntonella Rossetti · Cabinet of Commissioner Christophe HansenRole of animal health sector in contributing to a sustainable livestock sector in the EU; Trade and animal health and agricultural policies; Upcoming livestock strategy: content and timeline; Digitalisation in support of farmerssource ↗
- Critical Medicines Actsource ↗
- Introductionsource ↗
- Health policysource ↗
- Austauschsource ↗
- 2025-04-04ECMaurice Whelan · Head of UnitScientific roundtable discussion between the European Commission’s Joint Research Centre and the pharmaceutical industry on the topic of leveraging health data and data sciences for innovationsource ↗
- 2025-04-04ECTobias Wiesenthal · Head of UnitScientific roundtable discussion between the European Commission’s Joint Research Centre and the pharmaceutical industry on the topic of leveraging health data and data sciences for innovationsource ↗
- 2025-03-28ECDavid Ciliberti · Cabinet of Commissioner Glenn MicallefIntroductory meetingsource ↗
- European Healthcaresource ↗
- 2025-02-15ECHenna Virkkunen · Cabinet of Executive Vice-President Henna VirkkunenPrivate roundtable on transatlantic and global cooperation on tech organised on the margins of the Munich Security Conferencesource ↗
- EU Competitiveness Agendasource ↗
- Brain healthsource ↗
- Non-communicable diseasessource ↗
- Health policysource ↗
- European competitivenesssource ↗
Lobbying in these areas
Frequently asked
How many EU lobbying meetings has Merck disclosed?
Merck (EU Transparency Register no. 49654992078-52) appears in 41 disclosed meetings with EU officials and MEPs between 2024-09-30 and 2026-06-02: 20 with the European Commission and 21 with Members of the European Parliament.
What does Merck lobby on?
Merck's disclosed EU meetings most often concern Technology, Health, Industry, Transport. Every meeting and its topic is listed with its official source on this page.
Who does Merck meet in Brussels?
Across its disclosed meetings, Merck has met Commission officials including Vesna Loncaric, Stefan Fuehring, Jan Hendrik Dopheide, and MEPs including SOKOL Tomislav, KULJA András Tivadar, ANDRIUKAITIS Vytenis Povilas. These are counts of officially disclosed meetings, not a measure of influence.
Primary sources
- EU Transparency Register profile (no. 49654992078-52) ↗
- European Commission meeting disclosures ↗
- European Parliament — MEP meeting declarations ↗
Every meeting above is a public disclosure by the European Commission or a Member of the European Parliament; counts are of disclosed meetings only and are not a measure of influence. Methodology. Data © European Union (Decision 2011/833/EU) & the European Parliament.
Get the EU lobbying brief
We’ll email you when major new lobbying meetings are disclosed — free, no account, built from public EU data with every entry cited. We only email on real updates.